Top 25 Innovators - 2019

Under Nadauld’s leadership, Intermountain is using genomics in new and innovative ways. One breakthrough development decodes the genetic makeup of a patient’s unique cancer cells, allowing for more personalized treatment. Earlier this year, Nadauld announced the launch of a study using a half-million DNA samples to discover new connections between genetics and disease. It is the largest DNA mapping effort in the U.S. for a single population. Among some of the care improvements the Intermountain team has achieved: a 27% reduction in negative outcomes for blood clot patients and a 250% improvement in readmission rates for patients suffering from depression.